First Quadrant’s Integra LifeSciences IART Stock Holding History

First Quadrant’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,928	Closed	-$91K	–	661
2020 Q2	$91K	Sell	1,928 -4,104	-68%	-$202K	0.01%	570
2020 Q1	$269K	Sell	6,032 -20,653	-77%	-$1.08M	0.04%	358
2019 Q4	$1.55M	Buy	+26,685	New	+$1.59M	0.13%	151

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

First Quadrant's IART Position: Q3 2020 in Review

First Quadrant sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 1,928 shares — an estimated $91K sold.

First Quadrant first reported a position in IART in Q4 2019 and held it in 3 quarters. The position peaked at $1.55M in Q4 2019. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

First Quadrant reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
First Quadrant sold 1,928 Integra LifeSciences shares in Q3 2020, an estimated $91K.
First Quadrant first reported a position in Integra LifeSciences in Q4 2019 and held it in 3 quarters.
First Quadrant's Integra LifeSciences position peaked at $1.55M in Q4 2019.
237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on First Quadrant's 13F filing for Q3 2020, filed 28 Oct 2020.